Paul Jin > Goodwin > Washington DC, United States > Lawyer Profile
Goodwin Offices
901 NEW YORK AVENUE, NW
WASHINGTON DC 20001
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Paul Jin
Position
Partner
Career
Paul Jin is a partner in the firm’s Antitrust and Competition practice. Paul’s antitrust expertise covers a broad spectrum of commercial transactions, including mergers and acquisitions, B2B collaborations, and pricing and supply arrangements. Paul regularly serves clients by assessing transaction-related antitrust risk, negotiating terms of agreements, and determining the applicability of merger clearance filing requirements in both US and foreign jurisdictions. Paul routinely advocates on behalf of clients before the FTC, DOJ, and state regulators in connection with informal inquiries, Second Requests, third-party subpoenas, and conduct investigations. He also provides antitrust counseling on issues such as diligence and pre-closing conduct procedures, internal compliance programs, hiring and non-compete agreements, vendor agreements, interlocking directorates, and competitor collaboration guidelines. He has extensive knowledge of the Hart-Scott-Rodino (HSR) regime and has filed hundreds of notification forms with the FTC and DOJ for mergers, minority investments, asset acquisitions, and corrective fillings.
Prior to joining Goodwin in 2018, Paul was a partner in the antitrust practice at Wilson Sonsini Goodrich & Rosati, and previously practiced at Fried, Frank, Harris, Shriver & Jacobson LLP.
Education
JD, 2003, Northwestern University School of Law / BA, Economics, 2000, Duke University
Lawyer Rankings
United States > Antitrust > Merger control
Goodwin leverages its strength in key industry verticals across healthcare and life sciences, tech, and private equity, advising businesses and funds on strategic acquisitions, portfolio company mergers, and divestitures, with a strong record in both avoiding Second Requests from the DOJ and FTC as well as navigating investigations brought by regulatory authorities. The firm combines a prolific deal flow with involvement in high-profile, contentious merger clearances, notably advising iRobot on its acquisition by Amazon, and handling the antitrust elements of Nimbus Therapeutic’s defense of a hostile takeover attempt by Bristol Myers Squibb. The practice is led by Washington DC’s Andrew Lacy, who represents clients through the merger process, including litigation brought by the DOJ and FTC, alongside Arman Oruc, a life sciences antitrust specialist who divides his time between DC and Los Angeles. Also in DC, Paul Jin is noted for his HSR expertise.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Industry focus > Education
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- International Trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate
- M&A/corporate and commercial > Shareholder activism
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Healthcare > Service providers
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)